April 10, 2012 |
Screening longtime tobacco users for lung cancer would be less costly than the widely accepted practice of screening for breast, cervical and colorectal cancers and would reduce the death toll of lung cancer by an estimated 15,000 lives a year, according to a study released Monday that is likely to ignite debate on expanding healthcare coverage for smokers. Using the financial standards generally employed by health insurance companies, a group of actuarial economists calculated that annual low-dose CT scans of middle-aged Americans who have smoked the equivalent of a pack of cigarettes every day for 30 years would cost each insured American an extra 76 cents a month.
January 17, 2012 |
A medication for people with advanced colorectal cancer who have exhausted all other treatment options appears to slow tumor growth and extend life, according to new data. Bayer HealthCare, the makers of regorafenib, said it would seek Food and Drug Administration approval of the medication this year. If approved, regorafenib would be the first new treatment for colorectal cancer in more than five years. Although chemotherapy and other medications can extend life in people with metastatic cancer (cancer that has spread throughout the body)
November 11, 2011 |
Pour yourself a nice big bowl of whole-grain cereal. A study finds that diets high in fiber, particularly from cereal and whole grains, may reduce the risk of colon cancer. The study, released online today in the British Medical Journal , is a meta-analysis of 25 studies that examined the relationship between dietary fiber and colorectal cancer, the third most common type of cancer diagnosed among men and women in the U.S., according to the American Cancer Society. Previous studies have shown that dietary fiber may decrease colorectal cancer risk, but the authors of this study said it's not apparent whether certain types of fiber are key. After analyzing these papers they found that for every 10 grams of dietary fiber and cereal fiber there was a 10% reduced risk of colorectal cancer.
September 27, 2011 |
Men and women may need different screening guidelines for colonoscopies because of varying tumor rates between the genders. A study released Tuesday in the Journal of the American Medical Assn. analyzed the results of 44,350 colonoscopy screenings over four years; the tests covered adenomas (benign tumors), advanced adenomas, and colorectal cancer. Generally, screenings are recommended for men and women starting at age age 50 because colorectal rates begin to climb in the following decade.
July 6, 2011 |
Increased screening during the last decade for colorectal cancer, the nation's second-leading cause of cancer deaths, has put a sharp dent in the prevalence of the disease and in the number of deaths resulting from it, the Centers for Disease Control and Prevention said Tuesday. As screening for the disease among those ages 50 to 75 increased from half to two-thirds of that population, the prevalence rate fell from 52.3 cases per 100,000 in 2003 to 45.4 per 100,000 in 2007. The death rate fell from 19 per 100,000 to 16.7 per 100,000 during the same period, the agency reported in its Morbidity and Mortality Weekly Report . Those declines represent 66,000 fewer cancers during the period and 32,000 fewer deaths, the agency found.
June 17, 2011 |
Cancer death rates are still declining in the U.S., but some are declining faster than others -- and cancer remains the leading cause of death for Americans younger than 85. In short, we've made progress against the disease, but more work needs to be done. In an annual report released Friday, the American Cancer Society estimated that 1,596,670 new cancer diagnoses and more than 570,000 cancer deaths are expected to occur this year. It also announced that death rates fell by about 22% for men and 14% for women between 1990 and 2007.